Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...

A head-to-head study of 108 prostate cancer patients shows gallium-68 PSMA PET/CT detects bone metastases far more accurately ...

Chinese researchers have built a machine-learning nomogram that combines biparametric MRI radiomics, clinical variables, and ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...

A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...

Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...

Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with ...

A new theranostics suite is streamlining treatment and clinical trials for certain types of cancer, notably prostate cancer ...